Product Information
NYSTATIN-TRIAMCINOLONE CREAM is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $0.2233 per GM under NDC 45802088094. Its NADAC has been published 450 times since Jan 10, 2018.
FDA first approved this application on Aug 14, 2017. Its Orange Book therapeutic-equivalence code is AT.
Strength
100000; 1 [USP'U]/g; mg/g
Manufacturer
Padagis Israel Pharmaceuticals LtdNDC
45802088094
Classification
Generic
Dosage Form
CREAM
Route
TOPICAL
Effective Date
8/19/2026
Active Ingredients
NYSTATIN; TRIAMCINOLONE ACETONIDEApproval Type
Generic (ANDA)
FDA Application
ANDA208479FDA Approved
8/14/2017
TE Code
AT
On Market Since
11/27/2017
Pharmacological Classes
Price Statistics
The NADAC for NYSTATIN-TRIAMCINOLONE CREAM has been published 450 times since Jan 10, 2018, and over the history we have for it it has declined 90.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2233 per GM |
|---|---|
| All-time high | $2.2340 (Jan 10, 2018) |
| All-time low | $0.2047 (Nov 20, 2024) |
| 52-week high | $0.2808 |
| 52-week low | $0.2127 |
| Median price | $0.4493 |
| Average price | $0.5746 |
| Largest weekly change | +81.7% (Aug 21, 2024) |
| Weeks tracked | 450 |
| Tracking since | Jan 10, 2018 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 15% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of NYSTATIN-TRIAMCINOLONE CREAM?
The current National Average Drug Acquisition Cost (NADAC) for NYSTATIN-TRIAMCINOLONE CREAM, manufactured by Padagis Israel Pharmaceuticals Ltd, is $0.2233 per GM (NDC 45802088094), effective Aug 19, 2026.
How has the price of NYSTATIN-TRIAMCINOLONE CREAM changed over time?
Over the history we have for it, the NADAC for NYSTATIN-TRIAMCINOLONE CREAM has declined 90.0%. It has been tracked across 450 weekly CMS publications since Jan 10, 2018.
What are the highest and lowest recorded NADAC prices for NYSTATIN-TRIAMCINOLONE CREAM?
Since Jan 10, 2018, the NADAC for NYSTATIN-TRIAMCINOLONE CREAM has ranged from a low of $0.2047 (Nov 20, 2024) to a high of $2.2340 (Jan 10, 2018), with a median of $0.4493 per GM.
Are there cheaper alternatives to NYSTATIN-TRIAMCINOLONE CREAM?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NYSTATIN-TRIAMCINOLONE CREAM, is $0.1893 per GM — about 15% below NYSTATIN-TRIAMCINOLONE CREAM.
Who manufactures NYSTATIN-TRIAMCINOLONE CREAM?
NYSTATIN-TRIAMCINOLONE CREAM (NDC 45802088094) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.